
Biomednewsbreaks - Annovis Bio Inc. (NYSE: ANVS) To Present At Alzheimer's & Parkinson's Drug Development Summit
(MENAFN- Investor Brand Network) Annovis Bio (NYSE: ANVS) , a late-stage clinical drug platform company focused on neurodegenerative diseases, will participate in the 13th Alzheimer's & Parkinson's Drug Development Summit from March 18-20 in …